Venetoclax is used alone or in combination with obinutuzumab or rituximab to treat certain types of chronic lymphocytic leukemia (CLL; a type of cancer that begins in the white blood cells) or certain types of small lymphocytic lymphoma (SLL; a type of cancer that begins mostly in the lymph nodes).
Acalabrutinib waxaa loo isticmaalaa kaligiis ama obinutuzumab (Gazyva) lagu daaweeyaa Cudurka sanbabada ee daba-dheeraada (CLL; nooc ka mid ah kansarka ka bilaabma unugyada dhiigga cad) iyo lymphocytic lymphoma (SLL: nooc ka mid ah kansarka ka bilaabmaa unugyada dhiiga cad).